Citation: Rd. Gile et al., EFFECT OF LOVASTATIN ON THE DEVELOPMENT OF POLYCYSTIC KIDNEY-DISEASE IN THE HAN-SPRD RAT, American journal of kidney diseases, 26(3), 1995, pp. 501-507
Authors:
SWAN SK
CRARY GS
GUIJARRO C
ODONNELL MP
KEANE WF
KASISKE BL
Citation: Sk. Swan et al., IMMUNOSUPPRESSIVE EFFECTS OF LEFLUNOMIDE IN EXPERIMENTAL CHRONIC VASCULAR REJECTION, Transplantation, 60(8), 1995, pp. 887-890
Authors:
HALSTENSON CE
SWAN SK
COLLINS AJ
ELLEFSON J
PARR K
BLUE J
PRZYBELSKI RJ
Citation: Ce. Halstenson et al., PHARMACOLOGICAL PROFILE OF DIASPIRIN CROSS-LINKED HEMOGLOBIN (DCLHB) IN HEMODIALYSIS (HD) PATIENTS, Journal of the American Society of Nephrology, 5(3), 1994, pp. 451-451
Authors:
STPETER JV
SWAN SK
HALSTENSON CE
KASISKE BL
COLLINS AJ
ELLEFSON J
KEANE WF
Citation: Jv. Stpeter et al., ACCURATE AND EFFICIENT DETERMINATION OF RESIDUAL RENAL-FUNCTION (RRF)WITH IOHEXOL (IO) CLEARANCE IN HEMODIALYSIS (HD) PATIENTS, Journal of the American Society of Nephrology, 5(3), 1994, pp. 529-529
Citation: Rd. Gile et al., EFFECTS OF LOVASTATIN ON THE DEVELOPMENT OF POLYCYSTIC KIDNEY-DISEASE(PKD) IN HAN-SPRD RATS, Journal of the American Society of Nephrology, 5(3), 1994, pp. 624-624
Authors:
SWAN SK
KRAEMER MD
HENRY TD
COLLINS AJ
HERZOG CA
Citation: Sk. Swan et al., INCREASED INCIDENCE OF CORONARY-ARTERY ANEURYSMS IN PATIENTS WITH AUTOSOMAL-DOMINANT POLYCYSTIC KIDNEY-DISEASE (ADPKD), Journal of the American Society of Nephrology, 5(3), 1994, pp. 653-653
Authors:
CRARY GS
SWAN SK
ODONNELL MP
KASISKE BL
KATZ SA
KEANE WF
Citation: Gs. Crary et al., ANGIOTENSIN-II (AII) RECEPTOR ANTAGONIST LOWERS BLOOD-PRESSURE (BP) BUT DOES NOT REDUCE RENAL INJURY IN OBESE ZUCKER RATS, Journal of the American Society of Nephrology, 5(3), 1994, pp. 941-941
Authors:
SWAN SK
RADWANSKI E
CUTLER D
AFFRIME M
SCOTT M
HALSTENSON C
Citation: Sk. Swan et al., PHARMACOKINETICS OF FLUTAMIDE (F) IN PATIENTS WITH RENAL-INSUFFICIENCY (RI), Clinical pharmacology and therapeutics, 55(2), 1994, pp. 207-207
Authors:
SWAN SK
STPETER JV
KASISKE BL
COLLINS AC
KEANE WF
HALSTENSON CE
Citation: Sk. Swan et al., IOHEXOL CLEARANCE (CL(10)) AND RESIDUAL RENAL-FUNCTION (RRF) IN HEMODIALYSIS (HD) PATIENTS, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 207-207